CoChat

High HLA-DP Expression and Graft-versus-Host Disease

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Transplantation of hematopoietic cells from unrelated donors can cure blood disorders but carries a significant risk of acute graft-versus-host disease (GVHD). The risk is higher when the recipient and donor are HLA-DPB1-mismatched, but the mechanisms leading to GVHD are unknown. The HLA-DPB1 regulatory region variant rs9277534 is associated with HLA-DPB1 expression. We tested the hypothesis that the GVHD risk correlates with the rs9277534 allele linked to the mismatched HLA-DPB1 in the recipient. METHODS: We genotyped rs9277534 in 3505 persons to define rs9277534-DPB1 haplotypes. Among 1441 recipients of transplants from HLA-A,B,C,DRB1,DQB1-matched unrelated donors with only one HLA-DPB1 mismatch, linkage of the rs9277534 A and G alleles to the mismatched HLA-DPB1 was determined. HLA-DPB1 expression was assessed by means of a quantitative polymerase-chain-reaction assay. The risk of acute GVHD among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534G (high expression) was compared with the risk among recipients whose mismatched HLA-DPB1 allele was linked to rs9277534A (low expression). RESULTS: The mean HLA-DPB1 expression was lower with rs9277534A than with rs9277534G. Among recipients of transplants from donors with rs9277534A-linked HLA-DPB1, the risk of acute GVHD was higher for recipients with rs9277534G-linked HLA-DPB1 mismatches than for recipients with rs9277534A-linked HLA-DPB1 mismatches (hazard ratio, 1.54; 95% confidence interval [CI], 1.25 to 1.89; P<0.001), as was the risk of death due to causes other than disease recurrence (hazard ratio, 1.25; 95% CI, 1.00 to 1.57; P=0.05). CONCLUSIONS: The risk of GVHD associated with HLA-DPB1 mismatching was influenced by the HLA-DPB1 rs9277534 expression marker. Among recipients of HLA-DPB1-mismatched transplants from donors with the low-expression allele, recipients with the high-expression allele had a high risk of GVHD. (Funded by the National Institutes of Health and others.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1500140

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

Items 101–200 of 309

Metadata

Authors
Petersdorf, E. W., Malkki, M., O’hUigin, C., Carrington, M., Gooley, T., Haagenson, M. D., Horowitz, M. M., Spellman, S. R., Wang, T., & Stevenson, P.
Affiliations
  • University of Washington (US)
  • Fred Hutch Cancer Center (US)
  • Ragon Institute of MGH, MIT and Harvard (US)
  • Medical College of Wisconsin (US)
Venue
New England Journal of Medicine
Published
2015-08-13
Volume
373
Issue
7
Pages
599-609
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2258080942
Cited by
278
References
32
Citations by year
2026: 12 · 2025: 9 · 2024: 26 · 2023: 18 · 2022: 20 · 2021: 25 · 2020: 24 · 2019: 33 · 2018: 36 · 2017: 41 · 2016: 30 · 2015: 3
FWCI
28.78
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Defense (N000141310039)
  • Frederick National Laboratory for Cancer Research (HHSN261200800001E.)
  • National Institutes of Health (N00014-12-1-0142, #HHSN261200800001E, HHSN261200800001C, CA 18029)
  • U.S. Public Health Service (HHSH234200637015C)
  • U.S. Navy
  • National Heart, Lung, and Blood Institute (U01HL069294)
  • Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028, N00014-12-1-0142, N00014-12-1, N00014)
  • National Cancer Institute (CA18029, U24CA76518, HHSN261200800001E), CA76518, CA100019, P30CA015704, U24CA076518, R01CA100019, P01CA018029)
  • National Institute of Allergy and Infectious Diseases (AI069197, U01AI069197)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords
HLA-DPB1, HLA-DPB1 mismatch, unrelated donor transplantation, post-transplant mortality, hematopoietic stem cell transplantation
MeSH terms
Adolescent, Adult, Female, Genotype, Graft vs Host Disease, Histocompatibility Testing, Humans, Genetic Linkage, Male, Middle Aged, Regulatory Sequences, Nucleic Acid, Proportional Hazards Models, Polymerase Chain Reaction, Hematopoietic Stem Cell Transplantation, Polymorphism, Single Nucleotide, Young Adult, HLA-DP beta-Chains, Unrelated Donors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.